Barrow, Hanley, Mewhinney & Strauss’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PTEN
SG
AIM
Barrow, Hanley, Mewhinney & Strauss's PTEN Position: Q2 2025 in Review
Barrow, Hanley, Mewhinney & Strauss sold out of Patterson-UTI (PTEN) in Q2 2025, closing a stake of 1,972 shares — an estimated $16.2K sold.
Barrow, Hanley, Mewhinney & Strauss first reported a position in PTEN in Q2 2021 and held it in 10 quarters. The position peaked at $26K in Q4 2021. 361 funds tracked by Wall St. Rank hold PTEN as of Q2 2025.
- Barrow, Hanley, Mewhinney & Strauss reported no remaining Patterson-UTI position as of Q2 2025 after selling out during the quarter.
- Barrow, Hanley, Mewhinney & Strauss sold 1,972 Patterson-UTI shares in Q2 2025, an estimated $16.2K.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in Patterson-UTI in Q2 2021 and held it in 10 quarters.
- Barrow, Hanley, Mewhinney & Strauss's Patterson-UTI position peaked at $26K in Q4 2021.
- 361 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2025.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2025, filed 12 Aug 2025.